Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Neurology issues in schizophrenia.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Employment and multiple sclerosis: Policy, programming, and research recommendations.
Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.
Biomarkers of interferon Beta therapy in multiple sclerosis.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »